PTJ
AMAG

Paul Tudor Jones’s AMAG Pharmaceuticals AMAG Stock Holding History

Paul Tudor Jones’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,821
Closed -$167K – 1650
2020
Q2 		$167K Sell
21,821
-32,674
-60% -$250K 0.01% 1047
2020
Q1 		$337K Buy
54,495
+23,760
+77% +$209K 0.03% 644
2019
Q4 		$374K Sell
30,735
-9,797
-24% -$107K 0.02% 810
2019
Q3 		$468K Sell
40,532
-18,900
-32% -$199K 0.02% 732
2019
Q2 		$594K Sell
59,432
-1,350
-2% -$14.6K 0.02% 657
2019
Q1 		$783K Buy
60,782
+1,580
+3% +$23.5K 0.03% 547
2018
Q4 		$899K Sell
59,202
-325
-0.5% -$6.19K 0.02% 424
2018
Q3 		$1.19M Buy
59,527
+7,619
+15% +$173K 0.03% 408
2018
Q2 		$1.01M Buy
51,908
+39,564
+321% +$875K 0.04% 435
2018
Q1 		$249K Buy
+12,344
New +$209K 0.01% 802
2017
Q2 		– Sell
-22,300
Closed -$503K – 1496
2017
Q1 		$503K Buy
22,300
+11,100
+99% +$266K 0.02% 683
2016
Q4 		$390K Buy
+11,200
New +$335K 0.01% 861
2016
Q3 		– Sell
-375,500
Closed -$8.98M – 1824
2016
Q2 		$8.98M Buy
375,500
+89,300
+31% +$2.05M 0.19% 64
2016
Q1 		$6.7M Buy
+286,200
New +$6.79M 0.17% 85
2015
Q4 		– Sell
-15,800
Closed -$628K – 1917
2015
Q3 		$628K Sell
15,800
-123,325
-89% -$7.65M 0.02% 638
2015
Q2 		$9.61M Buy
139,125
+100,363
+259% +$6.31M 0.28% 62
2015
Q1 		$2.12M Buy
38,762
+30,331
+360% +$1.45M 0.07% 158
2014
Q4 		$359K Buy
+8,431
New +$305K 0.01% 937
2014
Q2 		– Sell
-22,400
Closed -$433K – 1392
2014
Q1 		$433K Buy
22,400
+6,800
+44% +$144K 0.02% 605
2013
Q4 		$379K Buy
+15,600
New +$367K 0.02% 747

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Paul Tudor Jones's AMAG Position: Q3 2020 in Review

Paul Tudor Jones sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 21,821 shares — an estimated $167K sold.

Paul Tudor Jones first reported a position in AMAG in Q4 2013 and held it in 20 quarters. The position peaked at $9.61M in Q2 2015. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

  • Paul Tudor Jones reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Paul Tudor Jones sold 21,821 AMAG Pharmaceuticals shares in Q3 2020, an estimated $167K.
  • Paul Tudor Jones first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 20 quarters.
  • Paul Tudor Jones's AMAG Pharmaceuticals position peaked at $9.61M in Q2 2015.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Tudor Investment Corp's 13F filing for Q3 2020, filed 16 Nov 2020.